Elena Lizarraga

Prof. Elena Lizarraga

Universidad de Navarra. Department of Pharmaceutical Technlology and chemistry
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Food Control
Verified
Journal Article
Closed access
MFMyra Evelyn Flores-Flores
Myra Evelyn Flores-Flores
ELElena Lizarraga
Elena Lizarraga
ACAdela Lopez De Cerain
Adela Lopez De Cerain
EPElena González Peñas
Elena González Peñas

1 April 2005 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KYKrassimira Yoncheva
Krassimira Yoncheva
ELElena Lizarraga
Elena Lizarraga
Juan M. IracheJuan M. Irache
Juan M. Irache

27 February 2020 in Toxins
Verified
Journal Article
Open access
PDF file
BABeatriz Arce-López
Beatriz Arce-López
ELElena Lizarraga
Elena Lizarraga
AVAriane Vettorazzi
Ariane Vettorazzi
EPElena González Peñas
Elena González Peñas
This manuscript reviews the state-of-the-art regarding human biological monitoring (HBM) of mycotoxins in plasma, serum and blood samples. After a comprehensive and systematic literature review, with a focus on the last five years, several aspects were analyzed and summarized: (a) the biomarkers analyzed and their encountered levels, (b) the analytical methodologies developed and (c) the relationship between biomarker levels and some illnesses. In the literature reviewed, aflatoxin B1-lysine (AFB1-lys) and ochratoxin A (OTA) in plasma and serum were the most widely studied mycotoxin biomarkers for HBM. Regarding analytical methodologies, a clear increase in the development of methods for the simultaneous determination of multiple mycotoxins has been observed. For this purpose, the use of liquid chromatography (LC) methodologies, especially when coupled with tandem mass spectrometry (MS/MS) or high resolution mass spectrometry (HRMS) has grown. A high percentage of the samples analyzed for OTA or aflatoxin B1 (mostly as AFB1-lys) in the reviewed papers were positive, demonstrating human exposure to mycotoxins. This review confirms the importance of mycotoxin human biomonitoring and highlights the important challenges that should be faced, such as the inclusion of other mycotoxins in HBM programs, the need to increase knowledge of mycotoxin metabolism and toxicokinetics, and the need for reference materials and new methodologies for treating samples. In addition, guidelines are required for analytical method validation, as well as equations to establish the relationship between human fluid levels and mycotoxin intake.

1 December 2011 in Food Control
Verified
Journal Article
Closed access
MIMaría Ibáñez-Vea
María Ibáñez-Vea
RMRosa Martínez
Rosa Martínez
EPElena González Peñas
Elena González Peñas
ELElena Lizarraga
Elena Lizarraga
ACAdela Lopez De Cerain
Adela Lopez De Cerain

1 May 2012 in Food Chemistry
Verified
Journal Article
Closed access
MIMaría Ibáñez-Vea
María Ibáñez-Vea
EPElena González Peñas
Elena González Peñas
ELElena Lizarraga
Elena Lizarraga
ACAdela Lopez De Cerain
Adela Lopez De Cerain

1 May 2012 in Food Control
Verified
Journal Article
Closed access
MIMaría Ibáñez-Vea
María Ibáñez-Vea
ELElena Lizarraga
Elena Lizarraga
EPElena González Peñas
Elena González Peñas
ACAdela Lopez De Cerain
Adela Lopez De Cerain